Roivant Sciences Ltd

{ "date": [ "202703", "202803", "202903", "203003", "203103" ], "revenue_estimate": [ 81.59, 429.13, 1607.21, 2750.79, 4302.3 ], "ebit_estimate": [ -1270.56, -975.24, -62.19, 896.9, 2092.24 ], "ebitda_estimate": [ -1287.93, -869.81, 69.24, null, null ], "net_income_estimate": [ -898.75, -782.16, -198.23, 520.03, 1369.28 ], "per_share_eps_estimate": [ -1.09, -1.16, -0.19, 0.8, 1.86 ], "eps_nri_estimate": [ -1.3, -1.04, 0.1, 1.12, 2.23 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ null, 8.88, null, null, null ], "pretax_income_estimate": [ -1100.77, -955.45, -24.5, 881.52, 2513.18 ], "operating_cash_flow_per_share_estimate": [ -1.39, -0.13, null, null, null ], "roa_estimate": [ -21.3, -25.8, null, null, null ], "roe_estimate": [ -27.83, -42.25, -16.81, null, null ], "gross_margin_estimate": [ 82, 81, 76, 82.5, 84 ], "operating_cash_flow_estimate": [ -997.05, -93.25, null, null, null ], "pettm_estimate": [ 0, 0, 0, 45.09, 19.32 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "473.88", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": 473.88, "future_ebit_estimate_growth": 60.74, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": 40.53, "future_pretax_income_estimate_growth": 68.53, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": -3.23, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712", "202803" ], "revenue_estimate": [ 2.13, 3.9, 14.03, 53.31, 27, 51.55, 95.42, 135.99 ], "ebit_estimate": [ -308.61, -316.33, -319.47, -298.73, -285.1, -271.54, -246.53, -224.7 ], "ebitda_estimate": [ -332.31, -337.77, -326.71, -253.18, null, null, null, null ], "net_income_estimate": [ -192.26, -207.5, -223.11, -250.12, -199.84, -181.25, -152.06, -127.5 ], "per_share_eps_estimate": [ -0.31, -0.33, -0.36, -0.36, -0.28, -0.26, -0.22, -0.18 ], "eps_nri_estimate": [ -0.31, -0.34, -0.33, -0.37, -0.28, -0.26, -0.22, -0.18 ], "dividend_estimate": [ null, null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null, null ], "pretax_income_estimate": [ -243.7, -266.02, -263.46, -262.96, -273.6, -261.04, -237.03, -216.2 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null, null ], "roe_estimate": [ -30.66, -38.56, -36.52, -36.98, null, null, null, null ], "gross_margin_estimate": [ 85, 85, 85, 85, 85, 85, 85, 85 ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "473.88", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": 473.88, "future_ebit_estimate_growth": 60.74, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": 40.53, "future_pretax_income_estimate_growth": 68.53, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": -3.23, "future_operating_cash_flow_per_share_estimate_growth": null }